GCTK — Glucotrack, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-12-10.
Performance
Technicals
Others in Healthcare
Measured signals that fired on GCTK
| date | signal | measured base rate |
|---|---|---|
| 2026-07-27 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-07-15 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-05-13 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-10-03 | Carter Erin Catherine Director | Grant or award | 386 | 0.00 | 0 |
| 2025-10-03 | Balo Andrew K Director | Grant or award | 1.3K | 0.00 | 0 |
| 2025-10-03 | Malave Luis Director | Grant or award | 463 | 0.00 | 0 |
| 2025-07-11 | Balo Andrew K Director | Grant or award | 3.3K | 0.00 | 0 |
| 2025-07-11 | Carter Erin Catherine Director | Grant or award | 1.0K | 0.00 | 0 |
| 2025-07-11 | Malave Luis Director | Grant or award | 1.2K | 0.00 | 0 |
| 2025-03-26 | BALLANTYNE JOHN Director | Grant or award | 4.1K | 0.00 | 0 |
| 2025-03-26 | Malave Luis Director | Grant or award | 2.1K | 0.00 | 0 |
| 2025-03-26 | Carter Erin Catherine Director | Grant or award | 1.9K | 0.00 | 0 |
| 2025-03-26 | Fischell Robert Director | Grant or award | 1.5K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 30.6K | 47.0K |
| Ikarian Capital, LLC | 29.8K | 45.8K |
| BOOTHBAY FUND MANAGEMENT, LLC | 8.8K | 13.5K |
| VANGUARD FIDUCIARY TRUST CO | 3.1K | 4.7K |
| ALERUS FINANCIAL NA | 2.6K | 4.0K |
| Tower Research Capital LLC (TRC) | 2.2K | 3.4K |
| UBS Group AG | 456 | 702 |
| HRT FINANCIAL LP | 26 | 40.6K |
| NFSG Corp | 22 | 34 |
| SBI Securities Co., Ltd. | 6 | 9 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| DEF 14A | 2026-08-10 | 2026-08-10 | on EDGAR ↗ |
| 8-K | 2026-08-10 | 2026-08-07 | on EDGAR ↗ |
| 8-K | 2026-08-05 | 2026-08-04 | on EDGAR ↗ |
| PRE 14A | 2026-07-31 | 2026-07-31 | on EDGAR ↗ |
| 8-K | 2026-07-30 | 2026-07-29 | on EDGAR ↗ |
| 8-K/A | 2026-07-29 | 2026-07-22 | on EDGAR ↗ |
| 8-K | 2026-07-27 | 2026-07-22 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Glucotrack, Inc. (GCTK) filed form 8-K · 2026-08-19 · SEC EDGAR
- Glucotrack, Inc. (GCTK) filed form 10-Q · 2026-08-14 · SEC EDGAR
Ask the AI about GCTK
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →